{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:44:57Z","timestamp":1790999097455,"version":"4.1.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>NAFLD is a series of liver disorders, and it has become the most prevalent hepatic disease to date. However, there are no approved and effective pharmaceuticals for NAFLD owing to a poor understanding of its pathological mechanisms. While emerging studies have demonstrated that m6A modification is highly associated with NAFLD. In this review, we summarize the general profile of NAFLD and m6A modification, and the role of m6A regulators including erasers, writers, and readers in NAFLD. Finally, we also highlight the clinical significance of m6A in NAFLD.<\/jats:p>","DOI":"10.1097\/hc9.0000000000000046","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T14:03:07Z","timestamp":1675087387000},"page":"e0046-e0046","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Roles of RNA m6A modification in nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-1237","authenticated-orcid":false,"given":"Jian","family":"Tan","sequence":"first","affiliation":[{"name":"The Department of Medical Genetics, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-9198","authenticated-orcid":false,"given":"Yue-fan","family":"Wang","sequence":"additional","affiliation":[{"name":"The Department of Medical Genetics, Naval Medical University, Shanghai, China"},{"name":"The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital Affiliated to Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-1096","authenticated-orcid":false,"given":"Zhi-hui","family":"Dai","sequence":"additional","affiliation":[{"name":"The Department of Medical Genetics, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3804-2455","authenticated-orcid":false,"given":"Hao-zan","family":"Yin","sequence":"additional","affiliation":[{"name":"The Department of Medical Genetics, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5376-0746","authenticated-orcid":false,"given":"Chen-yang","family":"Mu","sequence":"additional","affiliation":[{"name":"The Department of Medical Genetics, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0357-3969","authenticated-orcid":false,"given":"Si-jie","family":"Wang","sequence":"additional","affiliation":[{"name":"The Department of Medical Genetics, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2459-3923","authenticated-orcid":false,"given":"Fu","family":"Yang","sequence":"additional","affiliation":[{"name":"The Department of Medical Genetics, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2]]},"reference":[{"key":"R1-20240826","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"key":"R2-20240826","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s11427-019-1563-3","article-title":"Regulation of glucose and lipid metabolism in health and disease","volume":"62","author":"Chen","year":"2019","journal-title":"Sci China Life Sci"},{"key":"R3-20240826","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD From 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"R4-20240826","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12944-022-01640-y","article-title":"Fat mass and obesity-associated protein promotes liver steatosis by targeting PPARalpha","volume":"21","author":"Wei","year":"2022","journal-title":"Lipids Health Dis"},{"key":"R5-20240826","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R6-20240826","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-022-01510-2","article-title":"m6A modification: recent advances, anticancer targeted drug discovery and beyond","volume":"21","author":"Deng","year":"2022","journal-title":"Mol Cancer"},{"key":"R7-20240826","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.31220","article-title":"N(6)-methyladenosine reader protein YT521-B homology domain-containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes","volume":"73","author":"Zhou","year":"2021","journal-title":"Hepatology"},{"key":"R8-20240826","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/15548627.2020.1720431","article-title":"mA mRNA methylation regulates testosterone synthesis through modulating autophagy in Leydig cells","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"key":"R9-20240826","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ejhf.1672","article-title":"Changes in m6A RNA methylation contribute to heart failure progression by modulating translation","volume":"22","author":"Berulava","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R10-20240826","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-022-01508-w","article-title":"Insights into N6-methyladenosine and programmed cell death in cancer","volume":"21","author":"Liu","year":"2022","journal-title":"Mol Cancer"},{"key":"R11-20240826","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","article-title":"The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R12-20240826","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12943-019-1079-y","article-title":"Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3","volume":"18","author":"Ni","year":"2019","journal-title":"Mol Cancer"},{"key":"R13-20240826","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/lipd.12023","article-title":"Curcumin attenuates lipopolysaccharide-induced hepatic lipid metabolism disorder by modification of m(6) A RNA methylation in piglets","volume":"53","author":"Lu","year":"2018","journal-title":"Lipids"},{"key":"R14-20240826","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","article-title":"METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of FASN mRNA and promoting fatty acid metabolism","volume":"518","author":"Xie","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"R15-20240826","doi-asserted-by":"crossref","first-page":"751436","DOI":"10.3389\/fnut.2021.751436","article-title":"Integrated transcriptomic and translatomic inquiry of the role of betaine on lipid metabolic dysregulation induced by a high-fat diet","volume":"8","author":"Huang","year":"2021","journal-title":"Front Nutr"},{"key":"R16-20240826","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jcmgh.2021.10.007","article-title":"A novel humanized model of NASH and its treatment with META4, a potent agonist of MET","volume":"13","author":"Ma","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R17-20240826","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000519611","article-title":"Diagnostic and therapy of nonalcoholic fatty liver disease: a narrative review","volume":"38","author":"Roeb","year":"2022","journal-title":"Visc Med"},{"key":"R18-20240826","doi-asserted-by":"crossref","first-page":"21827","DOI":"10.1038\/s41598-021-00501-5","article-title":"Albino mice with the point mutation at the tyrosinase locus show high cholesterol diet-induced NASH susceptibility","volume":"11","author":"Kulathunga","year":"2021","journal-title":"Sci Rep"},{"key":"R19-20240826","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD)\u2014pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"R20-20240826","doi-asserted-by":"crossref","first-page":"761538","DOI":"10.3389\/fmed.2021.761538","article-title":"Liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies","volume":"8","author":"Qu","year":"2021","journal-title":"Front Med"},{"key":"R21-20240826","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement","volume":"6","author":"Eslam","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R22-20240826","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"R23-20240826","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/a-1862-9088","article-title":"Non-alcoholic fatty liver disease: current global burden","volume":"42","author":"El-Kassas","year":"2022","journal-title":"Semin Liver Dis"},{"key":"R24-20240826","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/tox.23404","article-title":"Polystyrene nanoplastics potentiate the development of hepatic fibrosis in high fat diet fed mice","volume":"37","author":"Li","year":"2022","journal-title":"Environ Toxicol"},{"key":"R25-20240826","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.jhepr.2020.100142","article-title":"Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN Study","volume":"2","author":"O\u2019hara","year":"2020","journal-title":"JHEP Rep"},{"key":"R26-20240826","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/liv.14825","article-title":"Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: a cost-of-illness analysis","volume":"41","author":"Schattenberg","year":"2021","journal-title":"Liver Int"},{"key":"R27-20240826","doi-asserted-by":"crossref","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep"},{"key":"R28-20240826","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nsmb.3162","article-title":"N6-methyladenosine\u2013encoded epitranscriptomics","volume":"23","author":"Liu","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"R29-20240826","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol Cell"},{"key":"R30-20240826","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"R31-20240826","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrg3724","article-title":"Gene expression regulation mediated through reversible m6A RNA methylation","volume":"15","author":"Fu","year":"2014","journal-title":"Nat Rev Genet"},{"key":"R32-20240826","doi-asserted-by":"crossref","first-page":"100538","DOI":"10.1016\/j.aohep.2021.100538","article-title":"Dysregulated N6-methyladenosine (m(6)A) processing in hepatocellular carcinoma","volume":"25","author":"Wang","year":"2021","journal-title":"Ann Hepatol"},{"key":"R33-20240826","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"R34-20240826","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer","volume":"18","author":"He","year":"2019","journal-title":"Mol Cancer"},{"key":"R35-20240826","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R36-20240826","doi-asserted-by":"crossref","first-page":"W548","DOI":"10.1093\/nar\/gkz479","article-title":"RNAmod: an integrated system for the annotation of mRNA modifications","volume":"47","author":"Liu","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R37-20240826","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R38-20240826","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tig.2017.04.003","article-title":"m(6)A in mRNA: an ancient mechanism for fine-tuning gene expression","volume":"33","author":"Roignant","year":"2017","journal-title":"Trends Genet"},{"key":"R39-20240826","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/epi-2019-0009","article-title":"Comprehensive analysis of differences of N-methyladenosine RNA methylomes between high-fat-fed and normal mouse livers","volume":"11","author":"Luo","year":"2019","journal-title":"Epigenomics"},{"key":"R40-20240826","doi-asserted-by":"crossref","first-page":"42271","DOI":"10.1038\/srep42271","article-title":"AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells","volume":"7","author":"Ueda","year":"2017","journal-title":"Sci Rep"},{"key":"R41-20240826","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.trecan.2022.02.010","article-title":"FTO in cancer: functions, molecular mechanisms, and therapeutic implications","volume":"8","author":"Li","year":"2022","journal-title":"Trends Cancer"},{"key":"R42-20240826","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1093\/nar\/gkac195","article-title":"Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes","volume":"50","author":"Kaur","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"R43-20240826","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol Cell"},{"key":"R44-20240826","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat Chem Biol"},{"key":"R45-20240826","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omto.2021.05.003","article-title":"Regulatory role and mechanism of m(6)A RNA modification in human metabolic diseases","volume":"22","author":"Zhang","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"R46-20240826","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41589-019-0231-8","article-title":"FTO controls reversible m(6)Am RNA methylation during snRNA biogenesis","volume":"15","author":"Mauer","year":"2019","journal-title":"Nat Chem Biol"},{"key":"R47-20240826","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2016.09.086","article-title":"Hepatic FTO expression is increased in NASH and its silencing attenuates palmitic acid-induced lipotoxicity","volume":"479","author":"Lim","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"R48-20240826","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-020-00385-4","article-title":"RNA N6-methyladenosine: a promising molecular target in metabolic diseases","volume":"10","author":"Li","year":"2020","journal-title":"Cell Biosci"},{"key":"R49-20240826","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbalip.2018.02.003","article-title":"FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells","volume":"1863","author":"Chen","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"R50-20240826","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/15476286.2020.1736868","article-title":"GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs","volume":"17","author":"Hu","year":"2020","journal-title":"RNA Biol"},{"key":"R51-20240826","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3390\/nu10111600","article-title":"Fat mass and obesity associated (FTO) gene and hepatic glucose and lipid metabolism","volume":"10","author":"Mizuno","year":"2018","journal-title":"Nutrients"},{"key":"R52-20240826","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1002\/jcb.26746","article-title":"FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation","volume":"119","author":"Kang","year":"2018","journal-title":"J Cell Biochem"},{"key":"R53-20240826","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7150\/ijbs.50003","article-title":"The emerging roles of m(6)A modification in liver carcinogenesis","volume":"17","author":"Pan","year":"2021","journal-title":"Int J Biol Sci"},{"key":"R54-20240826","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"key":"R55-20240826","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1101\/gad.309146.117","article-title":"Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m(6)A machinery component Wtap\/Fl(2)d","volume":"32","author":"Knuckles","year":"2018","journal-title":"Genes Dev"},{"key":"R56-20240826","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1038\/s41467-021-23892-5","article-title":"HAKAI is required for stabilization of core components of the m(6)A mRNA methylation machinery","volume":"12","author":"Bawankar","year":"2021","journal-title":"Nat Commun"},{"key":"R57-20240826","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","article-title":"Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases","volume":"63","author":"Wang","year":"2016","journal-title":"Mol Cell"},{"key":"R58-20240826","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","article-title":"METTL3-m(6)A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease","volume":"30","author":"Peng","year":"2022","journal-title":"Mol Ther"},{"key":"R59-20240826","doi-asserted-by":"crossref","first-page":"109968","DOI":"10.1016\/j.celrep.2021.109968","article-title":"m(6)A mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity","volume":"37","author":"Qin","year":"2021","journal-title":"Cell Rep"},{"key":"R60-20240826","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/s41467-021-27539-3","article-title":"The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"R61-20240826","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","article-title":"Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"30","author":"Yang","year":"2022","journal-title":"Mol Ther"},{"key":"R62-20240826","first-page":"1","article-title":"AS3MT facilitates NLRP3 inflammasome activation by m(6)A modification during arsenic-induced hepatic insulin resistance","author":"Qiu","year":"2022","journal-title":"Cell Biol Toxicol"},{"key":"R63-20240826","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","article-title":"Rethinking mA readers, writers, and erasers","volume":"33","author":"Meyer","year":"2017","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R64-20240826","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"R65-20240826","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13578-020-00502-3","article-title":"Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Cell Biosci"},{"key":"R66-20240826","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","article-title":"A unified model for the function of YTHDF proteins in regulating m(6)A-modified mRNA","volume":"181","author":"Zaccara","year":"2020","journal-title":"Cell"},{"key":"R67-20240826","doi-asserted-by":"crossref","first-page":"13911","DOI":"10.1093\/nar\/gku1116","article-title":"Solution structure of the YTH domain in complex with N6-methyladenosine RNA: a reader of methylated RNA","volume":"42","author":"Theler","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"R68-20240826","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"R69-20240826","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res"},{"key":"R70-20240826","doi-asserted-by":"crossref","first-page":"e1007412","DOI":"10.1371\/journal.pgen.1007412","article-title":"Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development","volume":"14","author":"Kasowitz","year":"2018","journal-title":"PLoS Genet"},{"key":"R71-20240826","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.molcel.2017.09.021","article-title":"Regulation of m(6)A Transcripts by the 3\u2019\u21925\u2019 RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline","volume":"68","author":"Wojtas","year":"2017","journal-title":"Mol Cell"},{"key":"R72-20240826","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.celrep.2018.10.068","article-title":"Circadian clock regulation of hepatic lipid metabolism by modulation of m(6)A mRNA methylation","volume":"25","author":"Zhong","year":"2018","journal-title":"Cell Rep"},{"key":"R73-20240826","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gutjnl-2013-305736","article-title":"The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62\/IGF2BP2-2 as a promoter of NAFLD and HCC?","volume":"63","author":"Simon","year":"2014","journal-title":"Gut"},{"key":"R74-20240826","doi-asserted-by":"crossref","first-page":"17839","DOI":"10.3748\/wjg.v20.i47.17839","article-title":"Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis","volume":"20","author":"Simon","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R75-20240826","doi-asserted-by":"crossref","first-page":"11944","DOI":"10.1074\/jbc.RA119.008778","article-title":"Liver-specific deletion of IGF2 mRNA binding protein-2\/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation","volume":"294","author":"Regu\u00e9","year":"2019","journal-title":"J Biol Chem"},{"key":"R76-20240826","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s13577-021-00593-1","article-title":"Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression","volume":"34","author":"Cheng","year":"2021","journal-title":"Hum Cell"},{"key":"R77-20240826","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"key":"R78-20240826","doi-asserted-by":"crossref","first-page":"eaau7116","DOI":"10.1126\/scitranslmed.aau7116","article-title":"Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1","volume":"11","author":"Peng","year":"2019","journal-title":"Sci Transl Med"},{"key":"R79-20240826","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2020.04.009","article-title":"Epitranscriptomics in liver disease: basic concepts and therapeutic potential","volume":"73","author":"Zhao","year":"2020","journal-title":"J Hepatol"},{"key":"R80-20240826","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R81-20240826","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13105-015-0420-1","article-title":"FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice","volume":"71","author":"Chen","year":"2015","journal-title":"J Physiol Biochem"},{"key":"R82-20240826","doi-asserted-by":"crossref","first-page":"e7299","DOI":"10.1590\/1414-431x20187299","article-title":"Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease","volume":"51","author":"Li","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"R83-20240826","doi-asserted-by":"crossref","first-page":"2053902","DOI":"10.1155\/2020\/2053902","article-title":"Prognostic value of an m6A RNA methylation regulator-based signature in patients with hepatocellular carcinoma","volume":"2020","author":"Wu","year":"2020","journal-title":"Biomed Res Int"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HC9.0000000000000046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T15:08:36Z","timestamp":1724684916000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HC9.0000000000000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/hc9.0000000000000046","relation":{},"ISSN":["2471-254X"],"issn-type":[{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"assertion":[{"value":"2022-10-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}